Cargando…

Dual therapy and diabetic kidney disease

Detalles Bibliográficos
Autor principal:	Desai, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663767/ https://www.ncbi.nlm.nih.gov/pubmed/26664205 http://dx.doi.org/10.4103/0971-4065.168441

Ejemplares similares

Optimal Early Diagnosis and Monitoring of Diabetic Kidney Disease in Type 2 Diabetes Mellitus: Addressing the Barriers to Albuminuria Testing
por: Christofides, Elena A., et al.
Publicado: (2021)

Dual protein kinase C alpha and beta inhibitors and diabetic kidney disease: a revisited therapeutic target for future clinical trials
por: Koya, Daisuke
Publicado: (2013)

Impact of empagliflozin on diabetic kidney disease
por: Koya, Daisuke
Publicado: (2017)

Diabetic Kidney Disease: The “Silent” Majority?
por: Yau, Amy, et al.
Publicado: (2021)

Beyond the Glomerulus—Kidney Tubule Markers and Diabetic Kidney Disease Progression
por: Bullen, Alexander L., et al.
Publicado: (2021)

Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease
por: Persson, Frederik, et al.
Publicado: (2019)

Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes
por: de Boer, Ian H., et al.
Publicado: (2018)

Getting a Notch Closer to Understanding Diabetic Kidney Disease
por: Ahn, Seon-Ho, et al.
Publicado: (2010)

A Transcriptional Blueprint for Human and Murine Diabetic Kidney Disease
por: Bhalla, Vivek, et al.
Publicado: (2013)

Chronic Kidney Disease and Diabetes–A Potential Causal Link
por: Lai, Shenghan
Publicado: (2016)

Novel anti-inflammatory drugs for the treatment of diabetic kidney disease
por: Heerspink, Hiddo J. L., et al.
Publicado: (2016)

Staying Connected: Transcriptomics in the Search for Novel Diabetic Kidney Disease Treatments
por: Terker, Andrew S., et al.
Publicado: (2021)

Is There a Sweet Spot for Nrf2 Activation in the Treatment of Diabetic Kidney Disease?
por: Hall, Evan T., et al.
Publicado: (2014)

Adenine crosses the biomarker bridge: from ‘omics to treatment in diabetic kidney disease
por: Drexler, Yelena, et al.
Publicado: (2023)

Progression of diabetic kidney disease: Who is at risk?
por: Jamale, T
Publicado: (2020)

Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician Perspective
por: Nicholas, Susanne B., et al.
Publicado: (2022)

Biomarkers for early diagnosis of diabetic kidney disease: still a long way to go
por: Kumar, Vivek, et al.
Publicado: (2022)

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment
por: Scott, David
Publicado: (2013)

Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
por: Faridi, Kamil F., et al.
Publicado: (2023)

Back to the Future: Glomerular Hyperfiltration and the Diabetic Kidney
por: Tuttle, Katherine R.
Publicado: (2017)

Continue or Discontinue Dual Antiplatelet Therapy in Major Surgical or Endoscopic Procedures
por: Cheon, Young Koog
Publicado: (2013)

Protective Effect of Nrf2 and Catalase in Maternal Diabetes-Induced Perinatal Hypertension and Kidney Disease
por: Vaziri, Nosratola D.
Publicado: (2012)

Addressing the Challenge of Potentially Hazardous Elements in the Reduction of Hypertension, Diabetes and Chronic Kidney Disease in the Caribbean
por: Fevrier-Paul, Adwalia, et al.
Publicado: (2021)

State-based Diabetes Surveillance Among Minority Populations
por: Desai, Jay
Publicado: (2004)

Bleach in the Diabetic Kidney Destabilizes Basement Membrane Collagen
por: Monnier, Vincent M.
Publicado: (2015)

Kidney Failure Trends in People with Diabetes: The Looming Epidemic
por: Sabanayagam, Charumathi, et al.
Publicado: (2021)

Combined effect of sodium–glucose cotransporter 2 and dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease
por: Araki, Shin‐ichi
Publicado: (2019)

Pregnancy in chronic kidney disease
por: Sahay, M.
Publicado: (2015)

Plant-based Protein Intake and Kidney Function in Diabetic Patients
por: Chauveau, Philippe, et al.
Publicado: (2019)

A Novel Mechanism of Regulation for Exosome Secretion in the Diabetic Kidney
por: Feng, Ye, et al.
Publicado: (2021)

Glycemic Variability and KIM-1–Induced Inflammation in the Diabetic Kidney
por: Tuttle, Katherine R., et al.
Publicado: (2021)

The modifiers of chronic kidney disease in autosomal dominant polycystic kidney disease and the role of the endothelin-1
por: Einollahi, Behzad, et al.
Publicado: (2016)

Kidney Dysfunction After Acute Heart Failure: Is Acute Kidney Disease the New Acute Kidney Injury?
por: Kwong, Y. Diana, et al.
Publicado: (2021)

Goal-directed therapy and acute kidney injury: as good as it gets?
por: Doyle, James F., et al.
Publicado: (2016)

Commentary on Intraglumerular dysfunction predicts kidney failure in the type 2 diabetes
por: Wada, Jun
Publicado: (2021)

Paving the way to precision medicine for diabetic kidney disease: the PRIORITY trial
por: Schechter, Meir, et al.
Publicado: (2020)

Non-albuminuric chronic kidney disease in diabetes: A different approach?
por: Borg, Rikke, et al.
Publicado: (2022)

Diabetes Therapy Podcast Collection: Language Matters in Diabetes
por: Kalra, Sanjay, et al.
Publicado: (2021)

Vitamin D and Chronic Kidney Disease
por: Kostoglou-Athanassiou, Ifigenia
Publicado: (2021)

New Insights into APOL1 and Kidney Disease in African Children and Brazilians Living With End-Stage Kidney Disease
por: Ross, Michael J.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7sd0j468sq8smkommbb11acnhd